Episodes List

Episode 4 - Dr. Richard Menzies and Dr. Jonathan Campbell - 4 months of Rifampin for latent TB

Episode 4 - Dr. Richard Menzies and Dr. Jonathan Campbell - 4 months of Rifampin for latent TB

09 Feb, 2019
Episode 4 - Dr. Richard Menzies and Dr. Jonathan Campbell - 4 months of Rifampin for latent TB

Episode 4 - Dr. Richard Menzies and Dr. Jonathan Campbell - 4 months of Rifampin for latent TB

09 Feb, 2019
Episode 3 - Matthew Dankner - Dual MAPK inhibition in a subset of BRAF mutant melanomas

Episode 3 - Matthew Dankner - Dual MAPK inhibition in a subset of BRAF mutant melanomas

12 Jul, 2018
Episode 3 - Matthew Dankner - Dual MAPK inhibition in a subset of BRAF mutant melanomas

Episode 3 - Matthew Dankner - Dual MAPK inhibition in a subset of BRAF mutant melanomas

11 Jul, 2018
Episode 2 - Devin Abrahami - DPP-4 inhibitors and incidence of IBD among patients with DMII

Episode 2 - Devin Abrahami - DPP-4 inhibitors and incidence of IBD among patients with DMII

14 May, 2018
Episode 2 - Devin Abrahami - DPP-4 inhibitors and incidence of IBD among patients with DMII

Episode 2 - Devin Abrahami - DPP-4 inhibitors and incidence of IBD among patients with DMII

13 May, 2018
Episode 1 - Paul Savage - A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer

Episode 1 - Paul Savage - A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer

24 Feb, 2018
Episode 1 - Paul Savage - A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer

Episode 1 - Paul Savage - A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer

24 Feb, 2018